--- title: 'Compensation Analyst at Iovance Biotherapeutics' canonical: 'https://feeny.ai/job/compensation-analyst-iovance-biotherapeutics-remote-zms89qrjwqtp' type: 'job' last_seen: '2026-10-15' --- # Compensation Analyst at Iovance Biotherapeutics - **Company:** Iovance Biotherapeutics - **Location:** Remote - **Compensation:** $150k–$165k - **Work type:** remote - **Posted:** 2026-10-06 - **Last confirmed live:** 2026-10-15 - **Apply:** https://job-boards.greenhouse.io/iovancebiotherapeutics/jobs/5444256008 ## Job description About Iovance Biotherapeutics, Inc. [Iovance Biotherapeutics](https://www.iovance.com/), Inc.  is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The [Iovance TIL platform](https://www.iovance.com/our-science/til-platform/) spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit [www.iovance.com](http://www.iovance.com/). Amtagvi® and its accompanying design marks, Proleukin®, Iovance®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on [www.iovance.com](http://www.iovance.com/). ## Overview Iovance is seeking a Compensation Analyst reporting directly to the Sr. Director, Total Rewards & HR Operations.  The Compensation Analyst serves as a key front‑ and back‑end partner to the business, providing advanced analytical expertise and strategic support across the organization. This role is responsible for balancing compensation best practices with practical flexibility, ensuring solutions are both compliant and business‑aligned. The analyst will translate complex compensation concepts into clear, actionable guidance for audiences at all levels, from frontline managers to senior leadership. Essential Functions and Responsibilities - Support the administration, development, and continuous improvement of compensation structures, programs, and policies, while also contributing to cross‑functional initiatives in Benefits, HR Operations, Reporting, and other Total Rewards areas. - Review proposed salary increases and provide feedback based on analysis of the labor market and internal equity. Review requests for new or revised classifications to determine appropriate salary grade assignment. Provide market analyses and consult on pay recommendations for both exempt/non-exempt teammates by partnering with HRBPs and Recruiting on pay decisions and policies. - Partner on the development, implementation, and administration of compensation programs, including wages, base salary, bonuses, and incentive structures that support business objectives. - Evaluate and refine job descriptions, ensuring alignment with external benchmarks and internal career frameworks. Assess FLSA exemption classifications and recommend appropriate salary ranges using job description management systems and collaboration with department leaders - Lead compensation-related technology projects, including enhancements to market pricing systems, job description management platforms, and automation initiatives that improve efficiency - Ensure compliance with regulatory requirements, overseeing compensation-related reporting, audits, and maintain adherence to labor laws and internal policies. - Perform annual and ad hoc compensation analyses to benchmark salaries and wages against national and global market data, supporting competitive pay positioning. - Prepare reports, dashboards, charts, and career path documents summarizing compensation analytics, job evaluation findings, and pay structure recommendations. - Facilitate and/or complete salary survey submissions based on team and organization needs - Optimize and provide continuous improvement ideas to Compensation / HRIS programs, seeking out and implementing efficiencies. - Other duties as assigned. Required Education, Skills, and Knowledge - Bachelor’s degree in HR, Business or related field required. - 6-8 years Compensation at a high-growth company(ies) administering broad-based compensation with exempt and non-exempt roles - 6-8 years Leading and supporting design of compensation architecture including job leveling and developing wage ranges, etc. - Deep knowledge of executive and non-executive compensation programs including equity planning and practices, base salary, variable pay and performance management, job evaluation, data analysis, research and predictive and project modeling. - Strong analytical skills with an emphasis on key insights, trends, issue identification and recommendations. - Strong problem-solving aptitude, creative, flexible and consultative; strong sense of business needs and making decisions based on data and emerging priorities; high integrity and accountability. - Ability to listen and use critical thinking to assess the needs and communicate accurate information concerning processes, plans and procedures in a collaborative, team-based manner. - Detail-oriented, proven ability to track, prioritize and drive to success multiple concurrent projects by analyzing data and driving sound decision-making. - Thrives in and enjoys a collaborative team setting and is driven by a desire to be innovative in a high energy, growing company environment. - Strong customer orientation. - Ability to handle highly sensitive, proprietary and confidential information appropriately - Life Sciences experience preferred. - International experience (policy and compliance) also preferred. - Workday experience strongly preferred. The physical demands described here represent those that an employee must meet to perform the essential functions of this job successfully. Reasonable accommodations may be made upon request to enable individuals to perform essential functions. Please contact Human Resources to request an accommodation. Physical Demands and Activities Required - Must be able to remain in a stationary position standing or sitting for prolonged periods of time. Mental: Clear and conceptual thinking ability; excellent judgment, troubleshooting, problem-solving, analysis, and discretion; ability to handle work-related stress; ability to handle multiple priorities simultaneously; and ability to meet deadlines Work Environment This position will work in an office setting. The statements contained in this document are intended to describe the general nature and level of work being performed by a colleague assigned to this description. They are not intended to constitute a comprehensive list of functions, duties, or local variances. Management retains the discretion to add or to change the duties of the position at any time. Iovance is committed to cultivating and offering a diverse and inclusive work environment. As an equal-opportunity employer, our employees and applicants will be considered without regard to an individual’s race, color, religion, sex, pregnancy, national origin, age, physical and mental disability, marital status, sexual orientation, gender identity, gender expression, genetic information, military and veteran status, and any other characteristic protected by applicable law. If you need assistance or accommodation to apply to one of our opportunities, please contact careers@iovance.com. #LI-remote The annual base salary we reasonably expect to pay is listed. Individual pay decisions depend on various factors, such as primary work location, complexity and responsibility of the role, job duties/requirements, and relevant education, experience and skills. Pay Transparency $150,000—$165,000 USD The statements contained in this document are intended to describe the general nature and level of work being performed by a colleague assigned to this description. They are not intended to constitute a comprehensive list of functions, duties, or local variances. Management retains the discretion to add or to change the duties of the position at any time. Iovance is committed to cultivating and offering a diverse and inclusive work environment. As an equal-opportunity employer, our employees and applicants will be considered without regard to an individual’s race, color, religion, sex, pregnancy, national origin, age, physical and mental disability, marital status, sexual orientation, gender identity, gender expression, genetic information, military and veteran status, and any other characteristic protected by applicable law. If you need assistance or accommodation to apply to one of our opportunities, please contact careers@iovance.com. By voluntarily providing information and clicking “Submit Application”, you explicitly consent to the collection and use of your personal information for the purposes described above and in our [Candidate Privacy Notice](https://www.iovance.com/privacy-policy/). ## About Iovance Biotherapeutics ## Company Overview - **One-liner**: Iovance Biotherapeutics is pioneering tumor infiltrating lymphocyte (TIL) cell therapies to develop personalized, one-time treatments for solid tumor cancers. - **Entity Type**: Public (NASDAQ: IOVA) - **Headquarters**: San Carlos, California, USA - **Founded**: 2007 (originally named Lion Biotechnologies, renamed Iovance Biotherapeutics in 2017) - **Founders**: Not publicly available (the company was formed through a merger and rebranding) ## Core Business - **Primary industry**: Biotechnology — Cell Therapy (Immuno-Oncology) - **Target customers**: B2B / B2G — Healthcare providers, clinical trial sites, and ultimately patients with advanced solid tumors (melanoma, non-small cell lung cancer, endometrial cancer, etc.) - **Mission or purpose statement**: To be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer, harnessing the immune system to recognize and attack diverse cancer cells. ## Products & Services - **Lifileucel (IOV-009)**: A one-time, personalized TIL therapy for advanced melanoma. It is the first approved TIL therapy for a solid tumor (FDA approved in early 2024 under the brand name Amtagvi). - **IOV-LUN-202**: An investigational TIL therapy for advanced non-small cell lung cancer (NSCLC) currently in Phase 2 clinical trials. - **IOV-END-201**: An investigational TIL therapy for advanced endometrial cancer currently in Phase 2 clinical trials. - **IOV-4001**: A next-generation, gene-edited TIL therapy (using TALEN technology to inactivate PD-1 expression) for solid tumors, currently in preclinical/early clinical development. - **IOV-3001**: An engineered IL-2 therapy (licensed from Novartis) designed to support TIL therapy efficacy, currently in preclinical development. - **Cell Therapy Manufacturing (iCTC)**: The company operates a 136,000-square-foot, state-of-the-art Cell Therapy Center in Philadelphia, PA, for proprietary GMP manufacturing of TIL therapies. ## Market Standing - **Valuation/Market Cap**: As of early 2026, market capitalization is approximately $2.5–3.0 billion (fluctuates with FDA news and clinical data). Check current price on NASDAQ: IOVA. - **Key Metric (Revenue)**: Iovance generated its first commercial revenue from Lifileucel/Amtagvi in 2024. Annual revenue for 2025 was approximately $180–220 million (estimate based on analyst reports; exact figure not yet fully disclosed). The company is not yet profitable. - **Key Metric (Funding)**: As a public company, Iovance has raised over $1.5 billion through public offerings and debt financings. Notable recent raise: a public offering in 2022 and subsequent at-the-market offerings. - **Notable Investors/Partners**: - Novartis (license partner for IOV-3001) - Major institutional investors (e.g., BlackRock, Vanguard, and several healthcare-focused funds) - Collaborations with major cancer centers for clinical trials (e.g., MD Anderson, Memorial Sloan Kettering, etc.) - **Growth Signals**: - FDA approval of Lifileucel (Amtagvi) in early 2024 — a landmark first-in-class approval for TIL therapy in solid tumors. - Rapid commercial launch and expansion of treatment centers across the U.S. - Multiple ongoing Phase 2/3 trials in large indications (NSCLC, endometrial cancer, frontline melanoma). - Investment in next-generation gene-edited TIL (IOV-4001) and engineered IL-2 (IOV-3001) to improve efficacy and expand addressable patient populations. ## Competitive Advantages - **First-to-market TIL therapy**: Iovance is the only company with an FDA-approved TIL therapy for a solid tumor (Amtagvi for melanoma), giving it a significant head start in manufacturing, commercial infrastructure, and physician education. - **Proprietary manufacturing platform**: The in-house iCTC facility in Philadelphia enables scalable, standardized GMP production of personalized TIL therapies, a major barrier to entry for competitors. - **Broad solid tumor pipeline**: Unlike CAR-T therapies (primarily effective in blood cancers), TIL therapy has shown promise across multiple solid tumor types, providing a large addressable market. - **Polyclonal T cell approach**: The therapy targets a broad range of neoantigens unique to each patient’s tumor, potentially reducing the risk of immune escape compared to single-target therapies. ## Strategic Focus - **Commercial expansion**: Scaling up the launch of Amtagvi for advanced melanoma and expanding treatment center network globally. - **Pipeline acceleration**: Advancing pivotal trials in NSCLC (IOV-LUN-202) and endometrial cancer (IOV-END-201) to secure additional FDA approvals. - **Next-generation innovation**: Developing gene-edited TIL (IOV-4001) to enhance persistence and efficacy, and engineered IL-2 (IOV-3001) to improve the TIL therapy cycle. - **Manufacturing optimization**: Continuing to improve manufacturing efficiency and turnaround time at the iCTC facility to support growing demand and reduce costs. ## Why Work Here - **Mission-driven culture**: The company is deeply patient-centric, with a clear focus on delivering transformative therapies to cancer patients. Employees often cite the meaningful impact of their work as a key motivator. - **Values**: Integrity, agility, innovation, collaboration, and excellence are core to the company’s operating philosophy. The culture emphasizes transparency, teamwork, and high ethical standards. - **Diversity, Equity, and Inclusion**: Iovance has a stated commitment to DEI, recognizing that internal diversity is critical to serving diverse patient populations and driving innovation. - **Remote/Hybrid policy**: Many roles (especially in clinical, medical affairs, marketing, and commercial functions) are remote or hybrid. Laboratory and manufacturing roles are based on-site in Philadelphia, PA (iCTC) or San Carlos, CA (HQ). - **Benefits**: Competitive salaries, annual cash bonuses, long-term incentives (stock options/RSUs), 401(k) with match, Employee Stock Purchase Plan, comprehensive medical/dental/vision (low employee cost), Health Savings Account contributions, paid parental leave, tuition assistance, wellness program (gym discounts), and professional development opportunities. - **Work environment**: Agile and fast-paced, typical of a biotech company at a critical growth stage. The company values data-driven decision-making and encourages employees to bring their best efforts every day. ## Sources 1. [iovance.com](https://www.iovance.com/) 2. [iovance.com - About Us](https://www.iovance.com/about-iovance-biotherapeutics/) 3. [iovance.com - Culture](https://www.iovance.com/culture/) 4. [job-boards.greenhouse.io](http://job-boards.greenhouse.io/iovancebiotherapeutics) ## Other roles at Iovance Biotherapeutics - [Cell Therapy Account Management - Indiana/Kentucky](https://feeny.ai/job/cell-therapy-account-management-indiana-kentucky-iovance-biotherapeutics-qb5tb3szkk6b) — Indianapolis, IN - [Manager, Manufacturing Operations](https://feeny.ai/job/manager-manufacturing-operations-iovance-biotherapeutics-philadelphia-1t4gxyzpbb4b) — Philadelphia, PA - [Cell Therapy Account Management (Denver, Colorado)](https://feeny.ai/job/cell-therapy-account-management-denver-colorado-iovance-biotherapeutics-denver-xx0z2nbqd1ja) — Denver, CO - [Associate Director, Medical Affairs (Medical Science Liaison) – Southeast Region](https://feeny.ai/job/associate-director-medical-affairs-medical-science-liaison-southeast-region-6j82hnv9ktve) - [Associate Director, Regulatory Affairs](https://feeny.ai/job/associate-director-regulatory-affairs-iovance-biotherapeutics-remote-gykv39fnzpfw) - [Instrumentation & Equipment Specialist II (3rd Shift Sunday - Wednesday, 10:00pm - 8:30am)](https://feeny.ai/job/instrumentation-equipment-specialist-ii-3rd-shift-sunday-wednesday-10-00pm-8-s8p923cgpe9a) — Philadelphia, PA - [Aseptic Manufacturing Technician I - Night Shift A [Contract to Hire]](https://feeny.ai/job/aseptic-manufacturing-technician-i-night-shift-a-contract-to-hire-iovance-gsn6naavvst6) — Philadelphia, PA - [Senior Manager, Supply Planning](https://feeny.ai/job/senior-manager-supply-planning-iovance-biotherapeutics-remote-4jvz0tazs3zj) - [Director, Clinical Operations](https://feeny.ai/job/director-clinical-operations-iovance-biotherapeutics-remote-kmc2mhrmcbxy) - [Clinical QA Specialist II, Clinical Specialist Providers (CSP)](https://feeny.ai/job/clinical-qa-specialist-ii-clinical-specialist-providers-csp-iovance-0xvh3ekvwwfv)